L. Persi et al., Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine, J ALLERG CL, 103(4), 1999, pp. 591-594
Background: The effect of H1-blockers may differ depending on the target or
gan.
Objective: A double-blind, placebo-controlled study was carried out to comp
are the effect of a 7-day treatment with loratadine (10 mg daily) or cetiri
zine (10 mg daily) on nasal challenge with grass pollen grains and skin tes
ts with allergen or histamine.
Methods: Twenty-four patients were enrolled, but the analysis was carried o
ut on 23, Nasal challenge was carried out by using 5-fold increasing number
s of pollen grains. Skin prick tests were done with serial concentrations o
f allergens and 1 concentration of histamine. Patients were tested in a cro
ss-over design, with each treatment being administered for the previous 7 d
ays and with a 2-week washout period.
Results: By comparison with placebo, loratadine and cetirizine increased si
gnificantly the threshold number of pollen grains required to induce a posi
tive nasal challenge (P < .001). There was no difference between loratadine
and cetirizine, Skin test responses to allergen were significantly reduced
by loratadine and cetirizine by comparison with placebo. Skin test respons
es to histamine were significantly decreased by the 2 H1-blockers, but they
were more profoundly decreased by cetirizine than by loratadine.
Conclusions: Both Hi-blockers reduced similarly allergen-induced skin test
and nasal challenge responses. Cetirizine was more effective on histamine s
kin test responses.